Purchase Order 75N91021P00136
Award Date
1/11/21
Potential Completion Date
1/10/25
Potential Value
$294K
Federal Agency
National Cancer Institute
Awardee
University Health Network
Ultimate Awardee
Not listed
PSC Category
R702 - Support- Management: Data Collection
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to procure existing clinical and treatment data on at least 500 pediatric cancer patients treated with photon therapy since 2007. The contract, valued at $97,021.21, is part of the NCI's Cancer Genome Atlas (TCGA) program and will support the U.S. Pediatric Photon Therapy Comparison...
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed-price purchase order to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to retrieve existing clinical and treatment data for pediatric cancer patients treated with photon therapy at the university's institution. The $118,611.00 contract is part of the US Pediatric Photon Therapy Comparison Cohort Study, a program focused on...
The National Cancer Institute (NCI) awarded a $249,814 firm fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to establish the US Pediatric Proton and Photon Therapy Cohort. This retrospective cohort study will compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...
The U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $150,577.00 firm fixed-price purchase order to Children's Hospital Los Angeles to retrieve existing clinical and treatment data for a comparison cohort of at least 500 pediatric cancer patients treated with photon therapy since 2007. The data will be used to evaluate the U.S. Pediatric Photon Therapy Comparison Cohort Study. There was no set-aside designation for this procurement....
The National Cancer Institute (NCI) awarded a $263,765.60 firm fixed-price delivery order contract to the University Health Network (UHN) in Ottawa, Canada. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase IDIQ and supports the procurement of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program. This contract is not set aside. UHN, doing business as the Toronto General And Western Hospital Foundation, is a major Canadian...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to the University of Florida Division of Sponsored Research. The contract has a potential value of $159,826.00 and a period of performance ending on March 15, 2023. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study, which aims to obtain data on pediatric cancer patients treated with proton or photon therapy. The contract was...
This is a $250,000.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Baylor College of Medicine for the US Pediatric Proton and Photon Therapy Cohort study. The contract, which has no set-aside designation, requires Baylor to retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric cancer patients treated with proton or photon therapy at their institution. This data will be used to evaluate the risks and benefits of...
The National Institutes of Health's National Cancer Institute awarded a $249,323 firm fixed price purchase order to The General Hospital Corporation Research Management Division, doing business as Massachusetts General Hospital. This contract is to serve as the Pediatric Proton and Photon Therapy Comparison Cohort Coordinating Center. Per the statement of work, the center will coordinate data collection and analysis from multiple pediatric cancer treatment sites comparing outcomes of patients...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute to The Washington University for $249,997 to provide medical record abstraction services in support of a study comparing pediatric proton and photon radiation therapy. The 14-month contract does not have a set-aside designation. The services will involve retrieving de-identified clinical and treatment data from medical records of pediatric cancer patients treated with proton or photon radiotherapy. This contract...